Literature DB >> 23912670

The Impact of Cancer Scale (IOC) in Italian long-term cancer survivors: adaptation and psychometric evaluation.

Barbara Muzzatti1, Cristiana Flaiban, Francesca Romito, Claudia Cormio, Maria Antonietta Annunziata.   

Abstract

PURPOSE: The Impact of Cancer Scale (IOC) is a self-assessment tool designed to capture the unique and multidimensional aspects of the quality of life of long-term cancer survivors. This paper describes the adaptation and psychometric evaluation of its Italian version.
METHODS: After the adaptation (i.e., removal of nonpertinent items and back-translation procedure), the Italian version of IOC has been administered to a sample of Italian long-term cancer survivors (people free from cancer and its treatments for at least 5 years) together with the Short Form 36 Health Survey Questionnaire, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, and the Post-Traumatic Growth Inventory.
RESULTS: Data on 304 participants were analyzed. Exploratory factor analysis revealed a three-factor structure composed of Uncertainty/Worry about Health & Future (13 items), Personal Growth & Altruism (14 items), and Dissatisfaction & Life Interferences (10 items). Internal consistency (Cronbach's alpha, >0.77) and temporal stability (Spearman's rho, >0.70) were good for all three factors. The obtained three factors correlated with the theoretically pertinent subscales of the other administered tools. To facilitate cross-cultural comparisons, reliability and convergent/divergent validity data for the eight-factor IOC structure already described in literature (Impact of Cancer Version 2) have been also provided.
CONCLUSIONS: This study supports the use of the IOC in Italy as a trifactorial instrument that is able to isolate aspects characteristic of the condition of long-term cancer survivorship. However, subsequent studies are needed to confirm these findings as well as shed more light on the validity of the IOC construct and its cultural variability.

Entities:  

Mesh:

Year:  2013        PMID: 23912670     DOI: 10.1007/s00520-013-1909-1

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  17 in total

1.  "The impact of cancer scale" version 1: psychometric testing of the Norwegian translation in a heterogeneous sample of cancer survivors.

Authors:  Alv A Dahl; Saevar Berg Gudbergsson; Anne Dørum; Sophie D Fosså; Astrid H Liavaag; Øystein Sørebø
Journal:  Qual Life Res       Date:  2011-11-02       Impact factor: 4.147

Review 2.  Physical and psychological long-term and late effects of cancer.

Authors:  Kevin D Stein; Karen L Syrjala; Michael A Andrykowski
Journal:  Cancer       Date:  2008-06-01       Impact factor: 6.860

3.  Assessing the impact of cancer: development of a new instrument for long-term survivors.

Authors:  Brad J Zebrack; Patricia A Ganz; Coen A Bernaards; Laura Petersen; Laura Abraham
Journal:  Psychooncology       Date:  2006-05       Impact factor: 3.894

Review 4.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

Review 5.  Assessing quality of life in long-term cancer survivors: a review of available tools.

Authors:  Barbara Muzzatti; M Antonietta Annunziata
Journal:  Support Care Cancer       Date:  2013-08-01       Impact factor: 3.603

6.  The Posttraumatic Growth Inventory: measuring the positive legacy of trauma.

Authors:  R G Tedeschi; L G Calhoun
Journal:  J Trauma Stress       Date:  1996-07

7.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

8.  Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.

Authors:  G Apolone; A Filiberti; S Cifani; R Ruggiata; P Mosconi
Journal:  Ann Oncol       Date:  1998-05       Impact factor: 32.976

Review 9.  Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence.

Authors:  C Foster; D Wright; H Hill; J Hopkinson; L Roffe
Journal:  Eur J Cancer Care (Engl)       Date:  2009-05       Impact factor: 2.520

10.  Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors.

Authors:  Catherine M Crespi; Sophia K Smith; Laura Petersen; Sheryl Zimmerman; Patricia A Ganz
Journal:  J Cancer Surviv       Date:  2009-12-06       Impact factor: 4.442

View more
  5 in total

1.  Comparison of the impact of cancer between British and US long-term non-Hodgkin lymphoma survivors.

Authors:  Shah-Jalal Sarker; Sophia K Smith; Kashfia Chowdhury; Patricia A Ganz; Sheryl Zimmerman; John Gribben; Ania Korszun
Journal:  Support Care Cancer       Date:  2016-11-08       Impact factor: 3.603

2.  Quality of life profile in Italian long-term cancer survivors.

Authors:  Barbara Muzzatti; Cristiana Flaiban; Antonella Surbone; Maria Antonietta Annunziata
Journal:  Qual Life Res       Date:  2014-10-24       Impact factor: 4.147

3.  The impact of cancer and quality of life among long-term survivors of breast cancer in Austria.

Authors:  Kathryn Bouskill; Michael Kramer
Journal:  Support Care Cancer       Date:  2016-06-30       Impact factor: 3.603

4.  Cancer-Related Psychological Distress in Lymphoma Survivor: An Italian Cross-Sectional Study.

Authors:  Giulia Agostinelli; Barbara Muzzatti; Samantha Serpentini; Michele Spina; Maria Antonietta Annunziata
Journal:  Front Psychol       Date:  2022-04-26

5.  International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer.

Authors:  Marieke van Leeuwen; Jacobien M Kieffer; Fabio Efficace; Sophie D Fosså; Michel Bolla; Laurence Collette; Marc Colombel; Ugo De Giorgi; Bernhard Holzner; Lonneke V van de Poll-Franse; Hendrik van Poppel; Jeff White; Ronald de Wit; Susanne Osanto; Neil K Aaronson
Journal:  Health Qual Life Outcomes       Date:  2017-05-11       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.